Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,536 | 271 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $688.17 | 44 | $0 (2024) |
| Lilly USA, LLC | $639.92 | 31 | $0 (2023) |
| Novo Nordisk Inc | $625.36 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $348.33 | 25 | $0 (2023) |
| PFIZER INC. | $266.99 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $256.58 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.29 | 14 | $0 (2023) |
| Abbott Laboratories | $223.52 | 12 | $0 (2023) |
| Allergan, Inc. | $198.94 | 19 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $190.71 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $277.65 | 15 | Novo Nordisk Inc ($41.42) |
| 2023 | $709.58 | 33 | Lilly USA, LLC ($252.10) |
| 2022 | $530.27 | 30 | Lilly USA, LLC ($149.58) |
| 2021 | $718.53 | 37 | Novo Nordisk Inc ($160.32) |
| 2020 | $253.11 | 14 | Amarin Pharma Inc. ($55.46) |
| 2019 | $299.26 | 14 | Horizon Therapeutics plc ($140.67) |
| 2018 | $683.04 | 41 | Janssen Pharmaceuticals, Inc ($298.30) |
| 2017 | $1,071 | 88 | Janssen Pharmaceuticals, Inc ($258.20) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Insomnia | ||||||
| 03/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.70 | General |
| Category: Cardiovascular | ||||||
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Insomnia | ||||||
| 02/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Cardiovascular | ||||||
| 12/18/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes Care | ||||||
| 12/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INSOMNIA | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2023 | Novo Nordisk Inc | Tresiba (Drug), Rybelsus, Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 08/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 985 | 1,717 | $386,376 | $133,531 |
| 2022 | 12 | 1,128 | 1,928 | $395,945 | $129,991 |
| 2021 | 16 | 1,244 | 2,254 | $460,044 | $150,361 |
| 2020 | 17 | 1,253 | 2,084 | $408,256 | $131,962 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 279 | 843 | $226,973 | $73,132 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $26,572 | $10,830 | 40.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 129 | 129 | $20,124 | $9,779 | 48.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 139 | $25,895 | $8,631 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 158 | $30,336 | $7,942 | 26.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 54 | 54 | $13,824 | $6,938 | 50.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 144 | 149 | $10,411 | $4,306 | 41.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $8,580 | $3,484 | 40.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 30 | 39 | $7,500 | $2,450 | 32.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 25 | $7,173 | $2,336 | 32.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 54 | 54 | $3,780 | $2,081 | 55.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,208 | $1,624 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 848 | $228,215 | $67,499 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 249 | $47,808 | $13,374 | 28.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 129 | $30,444 | $10,261 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $23,428 | $9,987 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 109 | 109 | $15,589 | $7,471 | 47.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 94 | $15,510 | $5,182 | 33.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 142 | 145 | $6,815 | $3,915 | 57.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 88 | 88 | $6,160 | $3,135 | 50.9% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 86 | 86 | $6,020 | $3,085 | 51.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 38 | 45 | $7,470 | $2,459 | 32.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 35 | 36 | $5,076 | $2,458 | 48.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,410 | $1,166 | 34.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 292 | 931 | $246,576 | $78,963 | 32.0% |
About Dr. Roberto Reyna, M.D
Dr. Roberto Reyna, M.D is a Internal Medicine healthcare provider based in Martinsburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639250558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Reyna, M.D has received a total of $4,543 in payments from pharmaceutical and medical device companies, with $277.65 received in 2024. These payments were reported across 272 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,536).
As a Medicare-enrolled provider, Reyna has provided services to 4,610 Medicare beneficiaries, totaling 7,983 services with total Medicare billing of $545,846. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Martinsburg, WV
- Active Since 10/18/2006
- Last Updated 04/07/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639250558
Products in Payments
- XARELTO (Drug) $462.74
- JARDIANCE (Drug) $402.22
- ELIQUIS (Drug) $322.00
- MOUNJARO (Drug) $259.58
- JANUVIA (Drug) $237.17
- INVOKANA (Drug) $192.53
- FARXIGA (Drug) $190.71
- TRELEGY ELLIPTA (Drug) $182.87
- Victoza (Drug) $171.88
- TRADJENTA (Drug) $141.50
- KRYSTEXXA (Biological) $140.67
- RYBELSUS (Drug) $128.23
- Rybelsus (Drug) $122.80
- Vascepa (Drug) $107.90
- FREESTYLE LIBRE 2 (Device) $104.23
- FreeStyle Libre 2 (Device) $101.09
- VIAGRA (Drug) $86.68
- Ozempic (Drug) $83.15
- BYSTOLIC (Drug) $79.91
- STEGLATRO (Drug) $70.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Martinsburg
Samuel Morris, Md, MD
Internal Medicine — Payments: $10,428
Dr. Phillip Aguila, Md, MD
Internal Medicine — Payments: $7,700
Dr. Michael Rezaian, M.d, M.D
Internal Medicine — Payments: $6,456
Dr. Robert Lynch, Md, MD
Internal Medicine — Payments: $4,735
Dr. Susila Rajakumar, M.d, M.D
Internal Medicine — Payments: $4,279
Vishal Gupta, Md, MD
Internal Medicine — Payments: $3,596